Education

The Foundation for the Development of Internal Medicine in Europe (FDIME) is offering Research Grants to Young Internists (up to age 38 yrs) to study in Research projects including all fields of General Internal Medicine, particularly polymorbidity and other common Internal Medicine conditions.
FDIME invites applications for Research Grant (up to 17,500 Euros) with an aim to promote research and to encourage exchanges within EFIM member countries. 

For more details please visit the FDIME Research Grants webpage at www.fdime.org

OR

We are pleased to announce that the 3rd European Advanced School of Internal Medicine, EASIM will take place from 2 - 4 July in Riga, Latvia after two years break. The program is designed to provide the applicants with clinical updates and also to help them to develop their non-technical skills such as communication, team working and conflict management, and to give them the best possible help as a young specialist in Internal Medicine.

EFIM condemns the attack on Ukraine.

We deplore the human casualties and ask to cease immediately the hostilities.

As physicians, we will never consider war as an option. War cannot be the response to any kind of action, as it generates only other suffering.

We would like to express our closeness to the Ukrainian colleagues who are experiencing the frustration and fear for the difficulties in taking care of their patients. 

We regret to inform you that due to the current pandemic situation we have decided to postpone the Winter school of 2022 to 2023!

We are pleased to announce that the Winter School of Internal Medicine 2022 will take place in Björkliden, Lappland, in northen Sweden from 14 - 18 February under the leadership of ESIM Director Dr. Jan Bergman.
The Winter school of 2022 will be organised by the Swedish Society of Internal Medicine (SIM).

The Foundation for the Development of Internal Medicine in Europe (FDIME) is offering Research Grants to Young Internists (up to age 38 yrs) to study in:
Research projects including all fields of General Internal Medicine, particularly polymorbidity and other common Internal Medicine conditions.

For details check the FDIME Research Grants webpage at www.fdime.org
or download:
Internal Medicine Grant Announcement
Internal Medicine Grant Application Form – closing date 15th July 2021

For further information:

Considering the current situation with the Covid-19 and the travel ban in Europe it has been decided to postpone the European Summer School of Internal Medicine, ESIM Summer 2021 to June 2022.

The school organisers together with the Spanish Society of Internal Medicine are working on confirming the new dates in June 2022.

Further details will follow in the coming months.

Thank you for your understanding.

EFIM is delighted to relaunch the Fellowship programme which is designed for all members of EFIM national societies who want to be part of a global community that share the same vision.

EFIM Fellowship is a professional credential that recognises and rewards physicians for  their outstanding achievements, and contribution to internal medicine and the community.
To find how to become EFIM Fellow please visit EFIM Fellowship page here.

We are pleased to inform you that the European Board of Internal Medicine, EBIM a joint collaboration between EFIM and the UEMS Section of Internal Medicine launched the Educational Platform online.
Access here the EBIM website: https://www.ebim-online.org/ .
EBIM is committed to advancing postgraduate education in internal medicine in Europe through guidance on the standardisation of training and practice of internal medicine within Europe for the benefit of patient care. 

The medical profession is facing increasing pressure to adapt its patient care to optimize the economic benefit for hospitals and practices.

Tocilizumab is a recombinant humanized monoclonal IL-6 receptor antibody indicated for the treatment of severe rheumatoid arthritis and other inflammatory disorders.Following clinical observation from China, a series of Italian studies have been carried out to evaluate the off-label use of tocilizumab in COVID-19 patients.
The European Journal of Internal Medicine (EJIM) has recently accepted for publication three articles on the off-label use of tocilizumab in patients with severe COVID-19.